Treating People with Parkinson's Disease: A New Pocket Guide to Help Make a Complex Disease Easier to Navigate


Live Webinar


Treating People with Parkinson's Disease: A New Pocket Guide to Help Make a Complex Disease Easier to Navigate
Wednesday, September 29, 2021
7:00-8:00 PM ET

This activity is not eligible for credit.

Overview

The creators of AMDA's new pocket guide, "Parkinson's Disease and Psychosis in the Post-Acute and Long-Term Care Setting," will introduce and discuss key elements of this new resource, designed to help physicians and advanced care practitioners better recognize features of Parkinson's disease and Parkinson's disease psychosis. Speakers will discuss appropriate and effective interventions and how to work with staff to gather the information needed to manage and monitor this complex disease. Participants will have an opportunity to ask questions during the live webinar or can submit questions ahead of time to Linda Lang at llang@paltc.org.

Learning Objectives

By the end of the webinar, participants should be able to: 

  • Express confidence in the diagnosis of Parkinson’s disease and discriminating it from parkinsonism and from other causes, including Parkinson’s Plus disorders. 
  • List the interventions appropriate to the appearance of various adverse drug reactions (ADRs) from Parkinson’s disease treatment. 
  • Recognize non-motor features and their impact on quality of life. 
  • Describe the interval history required to monitor a PALTC resident with Parkinson’s disease at the time of statutory visits. 
  • Differentiate Parkinson’s disease psychosis from other causes of behavioral problems/psychosis and choose appropriate treatment.

Credit Information

This activity is not eligible for credit.

Speakers

Alexander Baumgartner, MD; Nora Reznickova, MD; David Smith, MD, CMD; Lauren Seeberger, MD


Biographies
Alexander Baumgartner, MD, obtained his bachelor's degree in Mathematics and Biology at Gonzaga University and attended medical school at Brown University. Dr. Baumgartner completed his medical internship and neurology residency in Boston at Harvard Medical School/Beth Israel Deaconess Medical Center, where he served as chief resident in his final year. He is currently a second-year fellow in movement disorders at the University of Colorado. His interests in Neurology primarily include surgical treatments for movement disorders, namely deep brain stimulation. 

Nora Reznickova, MD, is a geriatrician specialized in advanced Parkinson's disease and related disorders and speak frequently on these topics as well as geriatric syndromes, function and frailty, palliative care, issues of nursing home placements and Medicare coverage.

David Smith, MD, CMD, is a solo practice PALTC physician and consulting geriatrician as well as nursing facility medical director in central Texas. Dr. Smith runs a consulting practice in PALTC litigation for both defense and plaintiff attorneys for over 20 years. He is also a past president of AMDA – The Society for Post-Acute and Long-Term Care Medicine.

Lauren Seeberger, MD, is a board-certified neurologist who completed neurology residency at Vanderbilt University followed by a fellowship in movement disorders at Rutgers-Robert Wood Johnson Medical School. She has been a practicing movement disorders specialist providing clinical care in three distinct settings: research institute, private practice, and academic medicine. Dr. Seeberger has created nationally recognized Centers of Excellence in research and care for Parkinson disease and Huntington disease at two different institutions and is an expert clinical research trialist. She has recently transitioned from her position as Professor of Neurology at the University of Colorado to join a new academic endeavor to develop a neurology residency program at CAMC in Charleston, West Virginia.

Disclosures

The following speakers have financial relationships to report: Alexander Baumgartner, MD - Grant/Research Support: University of Colorado; Lauren Seeberger, MD – Grant/Research Support: Biohaven, Parkinson Study Group, Huntington Study Group, Neurocrine Biosciences; David Smith, MD, CMD - Consultant: Acadia, Pharmerica Formulary Committee. 

Off-Label Discussion: Speakers will discuss off-label uses of medications to treat symptoms of Parkinson’s disease. 

The following AMDA Online Education Committee members have financial relationships to report: Robert Zorowitz, MD, MBA, CMD – United Health Group: Stock Shareholder; all others have no relationships to disclose. 

 AMDA staff have no financial relationships to disclose.